Clinical impact of systemic inflammation across different high-sensitivity C-reactive protein cutoffs in patients undergoing percutaneous coronary intervention
Authors:
- 1 October 2025
- journal article
- Published by Elsevier in Atherosclerosis
- Vol. 410, 120523
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Inflammatory risk and clinical outcomes according to polyvascular atherosclerotic disease status in patients undergoing PCIClinical Research in Cardiology, 2024
- IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trialNature Medicine, 2024
- Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trialsThe Lancet, 2023
- Effect of Elevated C-Reactive Protein on Outcomes After Complex Percutaneous Coronary Intervention for Angina PectorisThe American Journal of Cardiology, 2022
- A Test in ContextJACC, 2016
- C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysisThe Lancet, 2010
- High-Sensitivity C-Reactive Protein, Lipoprotein-Associated Phospholipase A2, and Outcome After Ischemic StrokeArchives of internal medicine (1960), 2006
- C-reactive protein in atherosclerosis: A causal factor?Cardiovascular Research, 2006
- The role of C-reactive protein in cardiovascular disease riskCurrent Cardiology Reports, 1999
- Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy MenNew England Journal of Medicine, 1997